Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Cited by (1,005)

Items 301–400 of 1,005

1. Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
   Hyunmee Kim, Hyeongsoo Kim, Seong-Kyung Cho, Jin‐Bae Kim, Boyoung Joung, Changsoo Kim · 2018 · Korean Circulation Journal
2. Control de la anticoagulación en pacientes con fibrilación auricular no valvular asistidos en atención primaria en España. Estudio PAULA
   Vivencio Barrios, Carlos Escobar, Luís Prieto, Genoveva Osorio, José Polo, José María Lobos, Diego Vargas, Nicolás García · 2015 · Revista Española de Cardiología
3. Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents
   Jeremy S. Paikin, Douglas S. Wright, Mark Andrew Crowther, Shamir R. Mehta, John W. Eikelboom · 2010 · Circulation
4. Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
   Katrin Kemp Gudmundsdottir, Tove Fredriksson, Emma Svennberg, Faris Al‐Khalili, Leif Friberg, Viveka Frykman, Ziad Hijazi, Mårten Rosenqvist, Johan Engdahl · 2019 · EP Europace
5. Cardiogenic and Aortogenic Brain Embolism
   Eleni Doufekias, Alan Z. Segal, Jorge R. Kizer · 2008 · Journal of the American College of Cardiology
6. Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure
   Jonathan Paul Piccini, Adrian F. Hernandez, Xin Zhao, Manesh R. Patel, William R. Lewis, Eric David Peterson, Gregg C. Fonarow · 2009 · Journal of the American College of Cardiology
7. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
   Katsushige Ono, Yu‐ki Iwasaki, Masaharu Akao, Takanori Ikeda, Kuniaki Ishii, Yasuya Inden, Kengo Kusano, Yoshinori Kobayashi, Yukihiro Koretsune, Tetsuo Sasano et al. · 2022 · Circulation Journal
8. The role of aspirin for stroke prevention in atrial fibrillation
   Gregory Y.H. Lip · 2011 · Nature Reviews Cardiology
9. Importance of Considering Competing Risks in Time-to-Event Analyses
   Husam Mohamed Abdel-Qadir, Jiming Fang, Douglas S. Lee, Jack V. Tu, Eitan Amir, Peter C. Austin, George Anderson · 2018 · Circulation Cardiovascular Quality and Outcomes
10. Atrial fibrillation and stroke
    Sylvia E. Choi, Dimitrios Sagris, Andrew M. Hill, Gregory Y.H. Lip, Azmil H. Abdul‐Rahim · 2022 · Expert Review of Cardiovascular Therapy
11. Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation
    Meytal Avgil Tsadok, Cynthia Anne Jackevicius, Vidal Essebag, Mark Jeffrey Eisenberg, Elham Rahme, Karin H. Humphries, Jack V. Tu, Hassan Behlouli, Louise Pilote · 2012 · Circulation
12. Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial
    Steven A. Lubitz, Steven J. Atlas, Jeffrey M. Ashburner, Ana T. Trisini Lipsanopoulos, Leila H. Borowsky, Wyliena Guan, Shaan S. Khurshid, Patrick T. Ellinor, Yuchiao Chang, David D. McManus et al. · 2022 · Circulation
13. Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
    Rienstra, Michiel, Tzeis, Stylianos, Bunting, Karina V, Caso, Valeria, Crijns, Harry J G M, De Potter, Tom J R, Sanders, Prashanthan, Svennberg, Emma, Casado-Arroyo, Ruben, Dwight, Jeremy et al. · 2024 · Europace
14. Body mass index and adverse events in patients with incident atrial fibrillation
    Overvad, Thure Filskov, Rasmussen, Lars Hvilsted, Skjøth, Flemming, Overvad, Kim, Lip, Gregory Y.H., Larsen, Torben Bjerregaard · 2013 · The American Journal of Medicine
15. Adverse prognosis of incidentally detected ambulatory atrial fibrillation
    Carlos Martínez, Anja Katholing, Saul Benedict Freedman · 2014 · Thrombosis and Haemostasis
16. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
    Anuraag R Kansal, Sonja V. Sorensen, Ray Gani, Paul J. Robinson, Feng Pan, Jonathan M Plumb, Martín Cowie · 2012 · Heart
17. Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke
    Peter Higgins, Peter W. Macfarlane, Jesse Dawson, Gordon T. McInnes, Peter Langhorne, Kennedy R. Lees · 2013 · Stroke
18. Factors Affecting the Adoption of an Electronic Word of Mouth Message: A Meta-Analysis
    Hamed Qahri‐Saremi, Ali Reza Montazemi · 2019 · Journal of Management Information Systems
19. EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
    Irina Savelieva, Stefano Fumagalli, Rose Anne Kenny, Stefan D. Anker, Athanase Bénétos, Giuseppe Boriani, Thomas Jared Bunch, Nikolaos Dagres, Sérgio Dubner, Laurent Fauchier et al. · 2022 · EP Europace
20. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation
    Gallego, Pilar, Roldán, Vanessa, Marin, Francisco, Gálvez, José, Valdés, Mariano, Vicente, Vicente, Lip, Gregory Y.H. · 2014 · The American Journal of Medicine
21. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system
    Janet M. Schnee, Kathy H. Fraeman, Kimberly Siu, Matthew W. Reynolds, Jenna M. Collins, Eric Schwartzman, Todd C. Villines · 2015 · Thrombosis and Haemostasis
22. The Society of Thoracic Surgeons Practice Guideline on the Prophylaxis and Management of Atrial Fibrillation Associated With General Thoracic Surgery: Executive Summary
    Hiran Chrishantha Fernando, Michael T. Jaklitsch, Garrett L. Walsh, James Edward Tisdale, Charles D. Bridges, John D. Mitchell, Joseph B. Shrager · 2011 · The Annals of Thoracic Surgery
23. Warfarin Pharmacology, Clinical Management, and Evaluation of Hemorrhagic Risk for the Elderly
    Laurie G. Jacobs · 2008 · Cardiology Clinics
24. Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients ― Fushimi AF Registry ―
    Yugo Yamashita, Ryuji Uozumi, Yasuhiro Hamatani, Masahiro Esato, Yeong‐Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe et al. · 2017 · Circulation Journal
25. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
    Darae Ko, Kueiyu Joshua Lin, Lily Gui Bessette, Su Been Lee, Allan J. Walkey, Susan C. Cheng, Erin Kim, Robert J. Glynn, Dae Hyun Kim · 2022 · JAMA Network Open
26. Left Atrial and Left Atrial Appendage 4D Blood Flow Dynamics in Atrial Fibrillation
    Michael Markl, Daniel C. Lee, Nicholas M. Furiasse, Maria L. Carr, Charles Elliott Foucar, Jason Ng, James Carr, Jeffrey J. Goldberger · 2016 · Circulation Cardiovascular Imaging
27. Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
    Tomas Forslund, Björn Wettermark, Paul Hjemdahl · 2015 · European Journal of Clinical Pharmacology
28. Early Versus Delayed Stroke After Cardiac Surgery: A Systematic Review and Meta‐Analysis
    Mario F.L. Gaudino, Mohamed Rahouma, Michele Di Mauro, Bobby Yanagawa, Ahmed Abouarab, Michelle R. Demetres, Antonino Di Franco, Mohammed J. Arisha, Dina Abdallah Ibrahim, Massimo Baudo et al. · 2019 · Journal of the American Heart Association
29. Initial Experience With a Novel Percutaneous Left Atrial Appendage Exclusion Device in Patients With Atrial Fibrillation, Increased Stroke Risk, and Contraindications to Anticoagulation
    Ali Massumi, Mihail Gabriel Chelu, Alireza Nazeri, Stephen May, Hamid Afshar-Kharaghan, Mohammad Saeed, Mehdi Razavi, Abdi Rasekh · 2013 · The American Journal of Cardiology
30. A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study)
    Lars O. Karlsson, Staffan Nilsson, Magnus Bång, Lennart E. Nilsson, Emmanouil Charitakis, Magnus Janzon · 2018 · PLoS Medicine
31. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation
    Sylvie Perreault, Simon de Denus, Brian White‐Guay, Robert Côté, Mireille E. Schnitzer, Marie‐Pierre Dubé, Marc Dorais, Jean‐Claude Tardif · 2019 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
32. Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With Rivaroxaban
    Wei Zhou, Markus Zorn, Peter Paul Nawroth, Ulf Buetehorn, Elisabeth Perzborn, Stefan Heitmeier, Roland C. Veltkamp · 2013 · Stroke
33. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination
    Femke Kaasenbrood, Monika Hollander, Frans Hendrik Rutten, Leo J. Gerhards, Arno Wilhelmus Hoes, Robert G. Tieleman · 2016 · EP Europace
34. Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation
    Jawad H. Butt, Ying Xian, Eric David Peterson, Peter Skov Olsen, Rasmus Rørth, Anna Gundlund, Jonas Bjerring Olesen, Gunnar Gislason, Christian Tobias Torp-Pedersen, Lars Køber et al. · 2018 · JAMA Cardiology
35. Global Left Atrial Strain Correlates with CHADS2 Risk Score in Patients with Atrial Fibrillation
    Samir Kanti Saha, Paula L. Anderson, Giuseppe Caracciolo, Anatoli Kiotsekoglou, Susan Wilansky, Satish Chandra Govind, Naoyo Mori, Partho P. Sengupta · 2011 · Journal of the American Society of Echocardiography
36. Incidence of Ischemic Stroke in Japanese Patients With Atrial Fibrillation Not Receiving Anticoagulation Therapy
    Shinya S. Suzuki, Takeshi Yamashita, Ken Okumura, Hirotsugu Atarashi, Masaharu Akao, Hisashi Ogawa, Hiroshi Inoue · 2014 · Circulation Journal
37. Screening for Atrial Fibrillation With Electrocardiography
    Daniel E Jonas, Leila C. Kahwati, Jonathan D. Y. Yun, Jennifer Cook Middleton, Manny J. L. Coker-Schwimmer, Gary N Asher · 2018 · JAMA
38. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
    Giuseppe Patti, Ilaria Cavallari, Felicita Andreotti, Paolo Calabrò, Plinio Lorenzo Cirillo, Gentian Denas, Mattía Galli, Enrica Golia, Ernesto Maddaloni, Rossella Marcucci et al. · 2018 · Nature Reviews Cardiology
39. Warfarin for atrial fibrillation in community‐based practise
    Adam J. Rose, Al Ozonoff, Lori E. Henault, Elaine M. Hylek · 2008 · Journal of Thrombosis and Haemostasis
40. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage
    Tze‐Fan Chao, Chia‐Jen Liu, Jo‐Nan Liao, Kang-Ling Wang, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Fa‐Po Chung et al. · 2016 · Circulation
41. Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS)
    Davíð O. Arnar, Georges H Mairesse, Giuseppe Boriani, Hugh G Calkins, Ashley Chin, Andrew J.S. Coats, Jean‐Claude Deharo, Jesper Hastrup Svendsen, Hein Heidbüchel, Rodrigo Isa et al. · 2019 · EP Europace
42. Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial
    Rustam Al‐Shahi Salman, Catriona Keerie, Jacqueline Stephen, Steff C. Lewis, John D. Norrie, Martin S. Dennis, David Ernest Newby, Joanna Marguerite Wardlaw, Gregory Y.H. Lip, Adrian Parry‐Jones et al. · 2021 · The Lancet Neurology
43. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
    Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, Pål Falck, Oddvar Solli, Christian Jonasson · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
44. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial
    Chris Wilkinson, Jianhua Wu, Samuel D. Searle, Oliver M. Todd, Marlous Hall, Vijay Kunadian, Andrew Paul Clegg, Kenneth J. Rockwood, Chris P Gale · 2020 · BMC Medicine
45. Atrial Fibrillation and Ischemic Stroke: A Clinical Review
    Ibrahim Migdady, Andrew Russman, Andrew Blake Buletko · 2021 · Seminars in Neurology
46. Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study
    PASSMAN, ROD, LEONG‐SIT, PETER, ANDREI, ADIN‐CRISTIAN, HUSKIN, ANNA, TOMSON, TODD T., BERNSTEIN, RICHARD, ELLIS, ETHAN, WAKS, JONATHAN W., ZIMETBAUM, PETER · 2016 · Journal of Cardiovascular Electrophysiology
47. Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -
    Masatsugu Hori, Stuart J. Connolly, Michael D. Ezekowitz, Paul A. Reilly, Salim Yusuf, Lars C. Wallentin, the RE-LY Investigators · 2011 · Circulation Journal
48. Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation
    Tze‐Fan Chao, Kang-Ling Wang, Chia-Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Fa‐Po Chung, Jo‐Nan Liao et al. · 2015 · Journal of the American College of Cardiology
49. Genetic Risk Prediction of Atrial Fibrillation
    Steven A. Lubitz, Xiaoyan Yin, Henry J. Lin, Matthew J. Kolek, J. Gustav Smith, Stella Trompet, Michiel Rienstra, Natalia S. Rost, Pedro L. Teixeira, Peter Almgren et al. · 2016 · Circulation
50. Review and update of the concept of embolic stroke of undetermined source
    Hans‐Christoph Diener, J. Donald Easton, Robert G. Hart, Scott Eric Kasner, Hooman Kamel, George Ntaios · 2022 · Nature Reviews Neurology
51. Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation
    Takeshi Yamashita, Yukihiro Koretsune, Masahiro Yasaka, Hiroshi Inoue, Yohko Kawai, Takenori Yamaguchi, Shinichiro Uchiyama, Masayasu Matsumoto, Satoshi Ogawa · 2012 · Circulation Journal
52. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong
    Chung‐Wah Siu, Gregory Y.H. Lip, Kwok–Fai Lam, Hung‐Fat Tse · 2014 · Heart Rhythm
53. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events
    Natalia S. Rost, Robert Patrick Giugliano, Christian Thomas Ruff, Sabina A. Murphy, Andrea E. Crompton, Andrew David Norden, Scott B. Silverman, Aneesh B. Singhal, José Carlos Nicolau, Bhupathi SomaRaju et al. · 2016 · Stroke
54. Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study
    Minjae Yoon, Pil‐Sung Yang, Eunsun Jang, Hee Joon Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Gregory Y.H. Lip et al. · 2018 · Thrombosis and Haemostasis
55. Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
    Paolo Gelosa, Laura Castiglioni, Marco Tenconi, Ludovico Baldessin, Giorgio Racagni, Alberto Corsini, Stefano Bellosta · 2018 · Pharmacological Research
56. Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate
    Gregory Y.H. Lip, Herbert Noack, Andreas Clemens, Jonathan M. Plumb, Neil Roskell · 2010 · Thrombosis and Haemostasis
57. Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation
    Oluseun O. Alli, Shepal Doshi, Saibal Kar, Vivek Yerrapu Reddy, Horst Sievert, Chris Mullin, Vijay Swarup, Brian K. Whisenant, David R. Holmes · 2013 · Journal of the American College of Cardiology
58. Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial
    Kuan H. Ng, Olga Shestakovska, Stuart J. Connolly, John W. Eikelboom, Álvaro Avezum, Rafael Díaz, Fernando Tomas Lanas, Salim Yusuf, Robert G. Hart · 2015 · Age and Ageing
59. Evolving Treatments for Arterial and Venous Thrombosis
    Noel Chan, John W. Eikelboom, Jeffrey Ian Weitz · 2016 · Circulation Research
60. The complexity of atrial fibrillation newly diagnosed after ischemic stroke and transient ischemic attack: advances and uncertainties
    Joshua O. Cerasuolo, Lauren E. Cipriano, Luciano Alberto Sposato · 2016 · Current Opinion in Neurology
61. Gender in atrial fibrillation: Ten years later
    Héctor I. Michelena, Brian D. Powell, Peter A. Brady, Paul A. Friedman, Michael D. Ezekowitz · 2010 · Gender Medicine
62. Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
    Nicholas T. Au, Allan E. Rettie · 2008 · Drug Metabolism Reviews
63. Periprocedural Intracardiac Echocardiography for Left Atrial Appendage Closure
    Sérgio Luis Berti, Umberto Paradossi, Francesco Meucci, Giuseppe Trianni, Apostolos Tzikas, Marco Rezzaghi, Miroslava Stolkova, Cataldo Palmieri, Fabio Mori, Gennaro Santoro · 2014 · JACC: Cardiovascular Interventions
64. Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
    Amanda R. Patrick, Jerry Avorn, Niteesh K. Choudhry · 2009 · Circulation Cardiovascular Quality and Outcomes
65. Differences among western European countries in anticoagulation management of atrial fibrillation
    Bettina Ammentorp, Harald Darius, Raffaele De Caterina, RICHARD JOHN SCHILLING, Josef Schmitt, José Luis Zamorano, Paulus F. Kirchhof, Jean‐Yves Le Heuzey · 2014 · Thrombosis and Haemostasis
66. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting
    David P. Faxon, John W. Eikelboom, Peter B. Berger, David R. Holmes, Deepak L. Bhatt, David J. Moliterno, Richard Clinton Becker, Dominick Joseph Angiolillo · 2011 · Circulation Cardiovascular Interventions
67. Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score: A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy
    Skjøth, Flemming, Nielsen, Peter, Larsen, Torben Bjerregaard, Lip, Gregory · 2015 · Thrombosis and Haemostasis
68. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation
    Ulf Landmesser, David R. Holmes · 2011 · European Heart Journal
69. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort
    James E. Ip, Albert L. Waldo, Gregory Y.H. Lip, Peter Malcolm Rothwell, David T. Martin, MALCOLM M. BERSOHN, Wassim K. Choucair, Joseph G. Akar, Mark S. Wathen, Pooyan Rohani et al. · 2009 · American Heart Journal
70. Contemporary Atrial Fibrillation Management: A Comparison of the Current AHA/ACC/HRS, CCS, and ESC Guidelines
    Jason G. Andrade, Laurent Macle, Stanley Nattel, Atul Verma, John A. Cairns · 2017 · Canadian Journal of Cardiology
71. Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
    Daehoon Kim, Jae‐Sun Uhm, Eue‐Keun Choi, Il-Young Oh, Jun Kim, Young Soo Lee, Junbeom Park, Jum Suk Ko, Kyoung‐Min Park, Jung‐Hoon Sung et al. · 2025 · JAMA
72. Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation
    Takahiko Tanigawa, Masato Kaneko, Kensei Hashizume, Mariko Kajikawa, Hitoshi Ueda, Masahiro Tajiri, John F. Paolini, Wolfgang Mueck · 2012 · Drug Metabolism and Pharmacokinetics
73. High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
    Vanessa Roldán, Francisco R. Marín, J. DÍAZ, Pilar Gallego, Eva Jover, M. Romera, Sergio Manzano‐Fernández, Teresa Casas, Mariano Valdés, Vicente Vicente et al. · 2012 · Journal of Thrombosis and Haemostasis
74. Anticoagulation in atrial fibrillation
    Benjamin Adam Steinberg, Jonathan Paul Piccini · 2014 · BMJ
75. Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation
    Jonas Bjerring Olesen, Laurent Fauchier, Deirdre A. Lane, Sophie Taillandier, Gregory Y.H. Lip · 2011 · CHEST Journal
76. Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: A systematic review and meta-analysis
    J. Taggar, T. Coleman, S. Lewis, C. Heneghan, Matthew Jones · 2015 · European Journal of Preventive Cardiology
77. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
    Karsten Bruins Slot, Eivind Berge · 2013 · Cochrane Database of Systematic Reviews
78. Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy
    Tsuneaki Sadanaga, Motoaki Sadanaga, Satoshi Ogawa · 2010 · Journal of the American College of Cardiology
79. Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
    Stephen M. Davis, Geoffrey Alan Donnan · 2012 · New England Journal of Medicine
80. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
    Jonas Oldgren, Ziad Hijazi, Johan Lindbäck, John Hunter Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher Bull Granger, Elaine M. Hylek, Renato D. Lópes et al. · 2016 · Circulation
81. Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA 2 DS 2 -VASc Score of 1
    Raed A. Joundi, Lauren E. Cipriano, Luciano Alberto Sposato, Gustavo Saposnik · 2016 · Stroke
82. CHA 2 DS 2 -VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) for Stroke in Asian Patients With Atrial Fibrillation
    Tae‐Hoon Kim, Pil‐Sung Yang, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Gregory Y.H. Lip · 2017 · Stroke
83. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism
    Thomas A. Mavrakanas, Henri Bounameaux · 2010 · Pharmacology & Therapeutics
84. Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
    Eleni Korompoki, Filippos T Filippidis, Peter Brønnum Nielsen, Angela Del Giudice, Gregory Y.H. Lip, Joji B. Kuramatsu, Hagen Bernhard Huttner, Jiming Fang, Sam Schulman, Joan Martí‐Fábregas et al. · 2017 · Neurology
85. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
    Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Gregory Y.H. Lip, Flemming Skjøth · 2014 · Thrombosis and Haemostasis
86. New oral anticoagulants in development
    Jeffrey Weitz · 2009 · Thrombosis and Haemostasis
87. Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study
    Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, Thure Filskov Overvad, Gregory Y.H. Lip · 2016 · Scientific Reports
88. Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation
    Tatjana Potpara, Marija M. Polovina, Marina M. Licina, Jelena Marinković, Milica S. Prostran, Gregory Y.H. Lip · 2012 · Circulation Arrhythmia and Electrophysiology
89. Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
    Michał Mazurek, Menno Volkert Huisman, Kenneth Jay Rothman, Miney Paquette, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Chang Ma, Kristina Zint et al. · 2017 · Thrombosis and Haemostasis
90. Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation
    Mohamad Adnan Alkhouli, Paul A. Friedman · 2019 · Journal of the American College of Cardiology
91. Atrial Fibrillation
    Renate B. Schnabel, Sandra Wilde, Philipp Sebastian Wild, Thomas F. Münzel, Stefan Blankenberg · 2012 · Deutsches Ärzteblatt international
92. Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis
    Albertsen, Ida Ehlers, Rasmussen, Lars Hvilsted, Overvad, Thure Filskov, Graungaard, Tina, Larsen, Torben Bjerregaard, Lip, Gregory Y.H. · 2013 · Stroke
93. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
    Friberg, Leif, Engdahl, Johan, Frykman, Viveka, Svennberg, Emma, Levin, Lars-Åke, Rosenqvist, Mårten · 2013 · EP Europace
94. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke
    Daniel J. Miller, Muhib Khan, Lonni R Schultz, Jennifer R. Simpson, Angelos M. Katramados, Andrew Russman, Panayiotis D. Mitsias · 2012 · Journal of the Neurological Sciences
95. Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
    Ziad Hijazi, Jonas Oldgren, Agneta G Siegbahn, Lars C. Wallentin · 2016 · Clinical Chemistry
96. The cardioprotective properties and the involved mechanisms of NaoXinTong Capsule
    Jihong Han, Hao Tan, Yajun Duan, Yuanli Chen, Yan Zhu, Buchang Zhao, Yong Wang, Xiaxiao Yang · 2019 · Pharmacological Research
97. D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial
    Christina Christersson, Lars C. Wallentin, Ulrika Andersson, John Hunter Alexander, Jack Ansell, Raffaele De Caterina, Bernard John Gersh, Christopher Bull Granger, M. Hanna, John David Horowitz et al. · 2014 · Journal of Thrombosis and Haemostasis
98. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
    Jens Cosedis Nielsen, Yenn‐Jiang Lin, Márcio Jansen de Oliveira Figueiredo, Alireza Sepehri Shamloo, Alberto Alfie, Serge Bovéda, Nikolaos Dagres, Darío Di Toro, Lee L. Eckhardt, Kenneth A. Ellenbogen et al. · 2020 · Journal of Arrhythmia
99. Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
    Paul Dorian, Thitima Kongnakorn, Hemant M. Phatak, Dale A. Rublee, Andreas Kuznik, Tereza Lanitis, Liu Lz, UH Iloeje, Luis G. Hernandez, Gregory Y.H. Lip · 2014 · European Heart Journal
100. Accuracy of mHealth Devices for Atrial Fibrillation Screening: Systematic Review
     Giebel, Godwin Denk, Gissel, Christian · 2019 · JMIR mHealth and uHealth